"Herpesvirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection by any virus from the family HERPESVIRIDAE.
| Descriptor ID |
D022283
|
| MeSH Number(s) |
D20.215.894.899.290
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Herpesvirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus Vaccines".
This graph shows the total number of publications written about "Herpesvirus Vaccines" by people in this website by year, and whether "Herpesvirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 4 | 1 | 5 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Herpesvirus Vaccines" by people in Profiles.
-
An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease. J Virol. 2019 11 15; 93(22).
-
Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine. Nanomedicine. 2019 02; 16:138-148.
-
Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. J Virol. 2018 09 01; 92(17).
-
Attenuated Phenotype and Immunogenic Characteristics of a Mutated Herpes Simplex Virus 1 Strain in the Rhesus Macaque. Viruses. 2018 05 02; 10(5).
-
Immune mechanisms induced by an HSV-1 mutant strain: Discrepancy analysis of the immune system gene profile in comparison with a wild-type strain. Vaccine. 2018 04 25; 36(18):2394-2402.
-
[Herpes zoster]. MMW Fortschr Med. 2018 Mar; 160(Suppl 1):35-42.
-
An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model. Viral Immunol. 2017 04; 30(3):178-195.
-
Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious. Avian Dis. 2013 Jun; 57(2 Suppl):498-502.
-
Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults. Vaccine. 2007 Jun 11; 25(24):4697-705.